|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.25 CNY | 0.00% |
|
+8.92% | -0.19% |
| 07-10 | China Includes Hubei Jumpcan Pharmaceutical's Granules for Colds in Children in Essential Drug List | MT |
| 06-09 | Jumpcan Pharma Gets Registration Certificate for Marboxil Tablets | MT |
| Market Cap | 24.19B 3.57B 3.12B 2.88B 2.65B 5B 344B 5.11B 34.4B 13.53B 168B 13.4B 13.11B 580B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 13.21B 1.95B 1.7B 1.57B 1.45B 2.73B 188B 2.79B 18.78B 7.39B 91.9B 7.32B 7.16B 316B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
37.54% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 week | +8.92% | ||
| Current month | +18.30% | ||
| 1 month | -1.24% | ||
| 3 months | +4.00% | ||
| 6 months | -0.11% | ||
| Current year | -0.19% |
| 1 week | 23.83 |  | 26.96 |
| 1 month | 21.13 | | 27.49 |
| Current year | 21.13 | | 29.6 |
| 1 year | 21.13 | | 29.6 |
| 3 years | 21.13 | | 45.18 |
| 5 years | 14.37 | | 45.18 |
| 10 years | 14.37 | | 54.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
Fei Cao
CEO | Chief Executive Officer | 43 | 19/12/2019 |
Hong Cun Yan
DFI | Director of Finance/CFO | 58 | 25/09/2022 |
Zhigang Chang
IRC | Investor Relations Contact | 29 | 21/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Qu Rong Huang
BRD | Director/Board Member | 64 | 09/03/2014 |
Fei Cao
BRD | Director/Board Member | 43 | 09/03/2014 |
Long Xiang Cao
CHM | Chairman | 69 | 09/03/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/12/25 | Buy | Director | 30,000 | 0.0033% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +8.92% | -5.20% | -4.44% | 3.57B | |
| -1.32% | +6.33% | -8.03% | -5.29% | 13.73B | |
| -3.30% | +12.63% | -26.94% | -50.04% | 5.45B | |
| -2.47% | +7.12% | +1.38% | -2.05% | 4.84B | |
| -5.06% | +8.62% | +9.27% | -34.00% | 4.29B | |
| -2.65% | -5.70% | +5.95% | -5.37% | 3.85B | |
| -3.45% | +9.54% | -3.88% | +11.29% | 3.51B | |
| -3.77% | -0.32% | -12.63% | -22.78% | 2.52B | |
| -2.82% | +2.80% | -1.62% | +50.74% | 1.92B | |
| -4.32% | +5.21% | -7.24% | -10.40% | 1.84B | |
| Average | -2.92% | +2.45% | -4.89% | -7.23% | 4.55B | |
| Weighted average by Cap. | -2.52% | +2.99% | -5.89% | -10.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | 1.72B 254M 222M 205M 189M 356M 24.49B 364M 2.45B 964M 12B 955M 934M 41.3B | - |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/07/26 | CN¥26.25 | 0.00% | 11,965,090 |
| 16/07/26 | CN¥26.25 | +1.47% | 8,729,828 |
| 15/07/26 | CN¥25.87 | +2.46% | 9,691,121 |
| 14/07/26 | CN¥25.25 | +2.60% | 8,440,479 |
| 13/07/26 | CN¥24.61 | +2.71% | 8,313,277 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600566 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition